Resultats globals: 6 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Documents de recerca, 1 registres trobats
Articles 5 registres trobats  
1.
8 p, 401.5 KB Impact of Medication Adherence on Mortality and Cardiovascular Morbidity : Protocol for a Population-Based Cohort Study / Giner Soriano, Maria (Universitat Autònoma de Barcelona. Departament de Farmacologia, Terapèutica i Toxicologia) ; Sotorra Figuerola, Gerard (Universitat Autònoma de Barcelona) ; Cortés, Jordi (Universitat Autònoma de Barcelona) ; Pera Pujadas, Helena (Institut Universitari d'Investigació en Atenció Primària. Unidad de Investigación Clínica y Ensayos Clínicos) ; Garcia Sangenis, Ana (Universitat Autònoma de Barcelona) ; Morros, Rosa (Institut Universitari d'Investigació en Atenció Primària. Unidad de Investigación Clínica y Ensayos Clínicos)
Cardiovascular disease (CVD) is a group of disorders of the heart and blood vessels, such as coronary heart disease (CHD), cerebrovascular disease, and peripheral artery disease. CVD is the leading threat to global health, whether measured by mortality, morbidity, or economic cost. [...]
2018 - 10.2196/resprot.8121
JMIR Research Protocols, Vol. 7, Issue 3 (March 2018) , art. e73  
2.
11 p, 3.4 MB Low-dose statin treatment increases prostate cancer aggressiveness / Caro-Maldonado, Alfredo (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Camacho, Laura (Biochemistry and Molecular Biology Department, University of the Basque Country, Bilbao, Spain) ; Zabala-Letona, Amaia (CIBERONC, Madrid, Spain) ; Torrano, Verónica (CIBERONC, Madrid, Spain) ; Fernández-Ruiz, Sonia (CIBERONC, Madrid, Spain) ; Zamacola-Bascaran, Kepa (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Arreal, Leire (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Valcárcel-Jiménez, Lorea (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Martín-Martín, Natalia (CIBERONC, Madrid, Spain) ; Flores, Juana M. (Department of Animal Medicine and Surgery, School of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain) ; Cortazar, Ana R. (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Zúñiga-García, Patricia (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Arruabarrena-Aristorena, Amaia (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Guillaumond, Fabienne (Université Aix-Marseille, Marseille, France) ; Cabrera, Diana (CIC bioGUNE, Bizkaia Technology Park, Derio, Spain) ; Falcón-Perez, Juan M. (IKERBASQUE, Basque foundation for science, Bilbao, Spain) ; Aransay, Ana M. (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain) ; Gomez-Muñoz, Antonio (Biochemistry and Molecular Biology Department, University of the Basque Country, Bilbao, Spain) ; Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carracedo, Arkaitz (IKERBASQUE, Basque foundation for science, Bilbao, Spain) ; Universitat Autònoma de Barcelona
Prostate cancer is diagnosed late in life, when co-morbidities are frequent. Among them, hypertension, hypercholesterolemia, diabetes or metabolic syndrome exhibit an elevated incidence. In turn, prostate cancer patients frequently undergo chronic pharmacological treatments that could alter disease initiation, progression and therapy response. [...]
2017 - 10.18632/oncotarget.22217
Oncotarget, Vol. 9 (october 2017) , p. 1494-1504  
3.
8 p, 630.1 KB Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism : Results of the DIANA Study / Millán Núñez-Cortés, Jesús (Calle del Dr. Esquerdo, 46, 28007 Madrid, Spain) ; Cases Amenós, Aleix (Barcelona, Spain) ; Ascaso Gimilio, Juan Francisco (Valencia, Spain) ; Barrios Alonso, Vivencio (Madrid, Spain) ; Pascual Fuster, Vicente (Centro de Salud Palleter, Castellón, Spain) ; Pedro-Botet Montoya, Juan Carles (Hospital del Mar (Barcelona)) ; Pintó Sala, Xavier (Unit of Lipids and Vascular Risk, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain) ; Serrano Cumplido, Adalberto (Centro de Salud de Repélega, Repélega, Portugalete, Vizcaya Spain) ; Universitat Autònoma de Barcelona
Despite the recognized clinical benefit of statins on cardiovascular prevention, providing correct management of hypercholesterolaemia, possible adverse effects of their use cannot be disregarded. Previously published data shows that there is a risk of developing diabetes mellitus or experiencing changes in glucose metabolism in statin-treated patients. [...]
2016 - 10.1007/s40256-016-0197-9
American Journal of Cardiovascular Drugs, Vol. 17 (november 2016) , p. 135-142  
4.
9 p, 695.8 KB Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness / Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Celma, Anna (Hospital de la Vall Hebron. Departament d'Urologia) ; Planas, Jacques (Hospital de la Vall Hebron. Departament d'Urologia) ; Placer, José (Hospital de la Vall Hebron. Departament d'Urologia) ; de Torres, Inés (Hospital de la Vall Hebron. Departament de Patologia) ; Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carles, Juan (Universitat Internacional de Catalunya. Department de Ciències Bàsiques) ; Reventós, Jaume (IDIBELL-Institut d'Investigació Biomèdica de Bellvitge) ; Doll, Andreas (DUniversitat Internacional de Catalunya. Department de Ciències Bàsiques)
The aim of this study was to analyze the relationship between statin use along with serum cholesterol levels and prostate cancer (PCa) detection and aggressiveness. Statin users of three years or more and serum cholesterol levels (SC) were assessed in 2408 men scheduled for prostate biopsy. [...]
2014 - 10.3390/ijms150813615
International journal of molecular sciences, Vol. 15 (august 2014) , p. 13615-13623  
5.
8 p, 611.0 KB Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator) / Lupón, Josep (Hospital Germans Trias i Pujol) ; Antonio, Marta de (Hospital Germans Trias i Pujol) ; Vila, Joan (Hospital del Mar. Institut Municipal d'Investigació Mèdica) ; Peñafiel, Judith (Hospital del Mar. Institut Municipal d'Investigació Mèdica) ; Galán, Amparo (Hospital Germans Trias i Pujol) ; Zamora Serrallonga, Elisabet (Hospital Germans Trias i Pujol) ; Urrutia de Diego, Agustín (Hospital Germans Trias i Pujol) ; Bayés Genís, Antoni (Hospital Germans Trias i Pujol)
Background: A combination of clinical and routine laboratory data with biomarkers reflecting different pathophysiological pathways may help to refine risk stratification in heart failure (HF). A novel calculator (BCN Bio-HF calculator) incorporating N-terminal pro B-type natriuretic peptide (NT-proBNP, a marker of myocardial stretch), high-sensitivity cardiac troponin T (hs-cTnT, a marker of myocyte injury), and high-sensitivity soluble ST2 (ST2), (reflective of myocardial fibrosis and remodeling) was developed. [...]
2014 - 10.1371/journal.pone.0085466
PloS one, Vol. 9, Issue 1 (January 2014) , p.e85466  

Documents de recerca 1 registres trobats  
1.
1 p, 1.2 MB Current status of treatments for cardiovascular aging : are statins a good option? / Navarro Gutiérrez, Judith ; Jiménez Altayó, Francesc, dir. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2016
Grau en Ciències Biomèdiques [832]  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.